These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17458151)

  • 21. Febuxostat versus allopurinol for gout.
    Gelber AC
    N Engl J Med; 2006 Apr; 354(14):1532-3; author reply 1532-3. PubMed ID: 16602151
    [No Abstract]   [Full Text] [Related]  

  • 22. Gout and related morbid conditions: pharmacological and SPA therapy.
    Petraccia L; Fraioli A; Liberati G; Lopalco M; Grassi M
    Minerva Med; 2008 Apr; 99(2):203-12. PubMed ID: 18431328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic diseases: gout.
    Falasca GF
    Clin Dermatol; 2006; 24(6):498-508. PubMed ID: 17113968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperuricemia and gout: new insights into pathogenesis and treatment.
    Pillinger MH; Rosenthal P; Abeles AM
    Bull NYU Hosp Jt Dis; 2007; 65(3):215-21. PubMed ID: 17922673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of diet in the management of gout: a comparison of knowledge and attitudes to current evidence.
    Shulten P; Thomas J; Miller M; Smith M; Ahern M
    J Hum Nutr Diet; 2009 Feb; 22(1):3-11. PubMed ID: 19192022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gout: what primary care physicians want to know.
    Dore RK
    J Clin Rheumatol; 2008 Oct; 14(5 Suppl):S47-54. PubMed ID: 18830091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Environmental Triggers of Hyperuricemia and Gout.
    Helget LN; Mikuls TR
    Rheum Dis Clin North Am; 2022 Nov; 48(4):891-906. PubMed ID: 36333002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Febuxostat: new drug. Hyperuricaemia: risk of gout attacks.
    Prescrire Int; 2009 Apr; 18(100):63-5. PubMed ID: 19585722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
    Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
    J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gout: on the brink of novel therapeutic options for an ancient disease.
    Bieber JD; Terkeltaub RA
    Arthritis Rheum; 2004 Aug; 50(8):2400-14. PubMed ID: 15334451
    [No Abstract]   [Full Text] [Related]  

  • 32. Factors associated with recurrent hospital admissions for gout: a case-control study.
    Hutton I; Gamble G; Gow P; Dalbeth N
    J Clin Rheumatol; 2009 Sep; 15(6):271-4. PubMed ID: 19734730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gout: Tips on diagnosis, treatment, and patient education.
    Montgomery M
    Nurse Pract; 2008 Dec; 33(12):28-32. PubMed ID: 19057345
    [No Abstract]   [Full Text] [Related]  

  • 34. Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout.
    Dalbeth N; Merriman T
    Rheumatology (Oxford); 2009 Mar; 48(3):222-6. PubMed ID: 19109320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Avoid purine-rich foods, drink a lot, reduce weight. The most important recipes against hyperuricemia].
    Benecke M
    MMW Fortschr Med; 2003 Aug; 145(31-32):36-8. PubMed ID: 14524070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of acute gout in hospitalized patients.
    Petersel D; Schlesinger N
    J Rheumatol; 2007 Jul; 34(7):1566-8. PubMed ID: 17610315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of gout.
    Schlesinger N
    Minerva Med; 2007 Dec; 98(6):759-67. PubMed ID: 18299687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Insufficient evidence for oral glucocorticoids as first-line therapy for acute gout].
    Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 2009; 153():A615. PubMed ID: 19785794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life and disability in patients with treatment-failure gout.
    Becker MA; Schumacher HR; Benjamin KL; Gorevic P; Greenwald M; Fessel J; Edwards L; Kawata AK; Frank L; Waltrip R; Maroli A; Huang B; ; Sundy JS
    J Rheumatol; 2009 May; 36(5):1041-8. PubMed ID: 19332629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical, humanistic, and economic outcomes of gout.
    Brixner DI; Ho MJ
    Am J Manag Care; 2005 Nov; 11(15 Suppl):S459-64; quiz S465-8. PubMed ID: 16300460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.